Racial differences on the outcome of simultaneous pancreas and kidney (SPK) transplantation have not been well studied. We compared mortality and graft survival of African Americans (AA) recipients to other racial/ethnic groups (non-AA) using the national data. We studied a total of 6585 adult SPK transplants performed in the United States between January 1, 2000 and December 31, 2007. We performed multivariate logistic regression analyses to determine risk factors associated with early graft failure and immune-mediated late graft loss. We used conditional Kaplan-Meier survival and multivariate Cox regression analyses to estimate late death-censored kidney and pancreas graft failure and death between the groups. Although there was no racial disparity in the first 90 days, AA patients had 38% and 47% higher risk for late deathcensored kidney and pancreas graft failure, respectively (p = 0.006 and 0.001). AA patients were twice more likely to lose the kidney and pancreas graft due to rejection (OR 2.31 and 1.86, p = 0.002 and 0.008, respectively). Bladder pancreas drainage was associated with inferior patient survival (HR 1.42, 95% CI 1.15, 1.75, p = 0.001). In the era of modern immunosuppresion, AA SPK transplant patients continue to have inferior graft outcome. Additional studies to explore the mechanisms of such racial disparity are warranted.
Introduction

Simultaneous pancreas and kidney (SPK) transplantation is the preferred treatment modality for suitable type 1 diabetic patients with end stage renal disease (ESRD) (1-3).
Beside improvement in quality of life, evidence suggests that a successful SPK transplant has the potential to improve cardiovascular risk profile, reduce the progression of macrovascular complication of diabetes and improve patient survival (4) (5) (6) (7) (8) (9) (10) . With the introduction of more potent immunosuppressive medications as maintenance therapy and widespread use of induction agents, the incidence of acute rejection has decreased and patient and graft survival has improved in SPK transplant patients in the recent era (11, 12) . (19, 20) . It is unclear whether such lower access to SPK transplantation in AA is the result of referral bias due to perceived inferiority in the outcome of SPK transplant for AA patients (20) . AA kidney transplant patients have higher risk for kidney graft loss and require increased levels of immunosuppression (21) (22) (23) (24) (25) . However, literature on such racial disparity regarding pancreas transplant outcome in the setting of SPK transplantation remains limited and controversial as most reports were generated from small numbers of AA SPK transplant patients involved in clinical trials or in single-center studies (26) (27) (28) . 
Although the incidence of type 1 diabetes mellitus in African Americans (AA) is lower than that of non-Hispanic white population, the AA diabetic patients have poorer metabolic control and higher incidence of end organ damage including ESRD (13-18). Type 1 diabetic AA ESRD patients have lower rate of access to SPK transplant registration compared to Caucasians
We hypothesized that with the improvement in surgical
Discussion
This study showed that despite the absence of racial differences in the early outcome of SPK transplants, The racial disparity in the outcome of chronic kidney disease in general, and of kidney transplantation in particular has been widely documented over the past 20 years (15, 23, 33) . For example, AA kidney transplant patients have an inferior kidney graft survival compared to non-AA kidney transplant patients and such difference has been attributed to multiple factors including enhanced immune reactivity and lower socioeconomic status (23, (33) (34) (35) . With enhanced immunosuppression, the incidence of acute rejection has been significantly lowered in all categories of transplant patients (34, 36, 37) . However, the reduction in acute rejection has not lead to the elimination of gap in the outcome between AA and non-AA kidney transplant patients (37) . (27) . In studies comparing the outcome of SPK versus kidney transplant alone using large registry data, AA patients had higher risk for kidney graft failure compared to non-AA patients (21, 39 
